Physician profile
Tyler E Dickson
NPI 1861856767
$8,334.68
in general payments reported to CMS, 2019-2025
30 companies · $841 in 2025
The $841 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $91.75 · 2021: $1,180 · 2022: $1,695 · 2023: $2,017 · 2024: $2,182 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,039.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,058.83 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $960.41 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $850.96 | 2021-2024 | Xarelto |
| Abbvie INC. | $847.31 | 2021-2025 | Teflaro, Dalvance, Avycaz |
| Gilead Sciences, INC. | $651.99 | 2019-2025 | Veklury |
| Pfizer INC. | $640.20 | 2020-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $482.66 | 2022-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $366.22 | 2021-2025 | Dificid, Zerbaxa, Verquvo |
| Astrazeneca Pharmaceuticals Lp | $365.22 | 2021-2025 | Fasenra, Lokelma, Farxiga |
| Alnylam Pharmaceuticals INC. | $284.62 | 2022-2024 | Givlaari |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $265.08 | 2021-2025 | Lifevest |
| Paratek Pharmaceuticals, INC. | $227.21 | 2021-2024 | Nuzyra |
| Boston Scientific Corporation | $201.40 | 2021-2024 | Watchman Flx, Watchman Access System |
| Alexion Pharmaceuticals, INC. | $173.06 | 2021-2025 | Ultomiris |
| Philips North America LLC | $134.90 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $122.71 | 2022-2023 | Orbactiv, Kimyrsa, Vabomere |
| E.R. Squibb & Sons, L.L.C. | $121.01 | 2021-2024 | Eliquis |
| Alkermes, INC. | $115.01 | 2019 | |
| Scpharmaceuticals INC. | $112.01 | 2024-2025 | |
| Portola Pharmaceuticals, LLC | $107.59 | 2019 | |
| Electromed, INC. | $50.35 | 2022-2024 | Smartvest |
| Bioxcel Therapeutics, INC. | $28.06 | 2023 | Igalmi |
| Inari Medical, INC. | $28.06 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Insmed, INC. | $23.17 | 2022 | |
| Cmp Pharma, INC. | $23.16 | 2021 | |
| Abbott Laboratories | $22.19 | 2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $20.80 | 2019 | |
| Kestra Medical Technology Services, INC. | $19.00 | 2024 | Assure Wcd |
| Glaxosmithkline, LLC. | $15.77 | 2025 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $15.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Dickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.